Rio2 Limited
TSX:RIO.TOGold
-$0.14 today
- Market cap
- $1.27B
- Beta
- 2.12
- P/E (TTM)
- 111.1
- EPS (TTM)
- $0.02
Volume 1.63M
Average 1.36M
RIO.TO Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Rio2 LimitedTSX: RIO.TO
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development remains negative
Q1 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How RIO.TO compares with its peers on the latest reported figures
- Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
- Research & development amounts to 0.0% of revenue for RIO.TO, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
RIO.TORio2 Limited | LTM Mar 2026 | $0 USD | — | — | 0.0% |
GTWO.TOG2 Goldfields Inc. | LTM Feb 2026 | CA$0 CAD | — | — | 0.0% |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
ABRA.TOAbraSilver Resource Corp. | LTM Jun 2026 | CA$0 CAD | — | — | — |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Apr 2026 | CA$0 CAD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding RIO.TO) | — | — | — | 0.0% | |
Competitors are the stored peer set for RIO.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 568.17K | 2.91M | 2.32M | 439.82K | 669.52K |
| Gross Profit | (568.17K) | (2.91M) | (2.32M) | (439.82K) | (669.52K) |
| Gross Margin | — | — | — | — | — |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 11.13M | 14.67M | 5.24M | 6.64M | 13.48M |
| Operating Expenses | 11.13M | 11.61M | 6.1M | 8.86M | 13.57M |
| Depreciation & Amortization | 293.11K | 2.5M | 2.03M | 242K | 669.52K |
| EBITDA | (10.22M) | 2.42M | (7.19M) | 2.83M | (13.57M) |
| EBITDA Margin | — | — | — | — | — |
| Operating Income | (11.89M) | (13.46M) | (7.97M) | (8.95M) | (14.24M) |
| Operating Margin | — | — | — | — | — |
| Interest Income | 15K | 53.69K | 249.43K | 659K | 908.63K |
| Interest Expense | 0 | 2.19M | 14.75K | 2.6M | 0 |
| Other Income / Expenses | 1.38M | 11.63M | (4.37M) | 8.95M | 362.23K |
| Income Before Tax | (10.51M) | (2.27M) | (12.34M) | (7.97K) | (13.88M) |
| Pre-Tax Margin | — | — | — | — | — |
| Income Tax Expense | 16.07K | 33.02K | 16K | 13K | 0 |
| Net Income | (10.53M) | (2.3M) | (12.33M) | (21K) | (13.88M) |
| Net Margin | — | — | — | — | — |
| EPS (Basic) | (0.05) | (0.01) | (0.06) | (0.00) | (0.03) |
| EPS (Diluted) | (0.05) | (0.01) | (0.06) | (0.00) | (0.03) |
| Weighted Avg Shares | 220.23M | 256.84M | 258.48M | 318.6M | 428.27M |
| Weighted Avg Shares (Diluted) | 220.23M | 256.84M | 258.48M | 318.6M | 428.27M |
Rio2 Limited
TSX:RIO.TO
Intrinsic Alpha fair value
Locked
Current Price
$2.32
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.